Finance

Beta
Ask
Lists
RLYB:NASDAQ
Rallybio Corp
$15.97
+0.31%
(+0.050) 1D
Jun 18, 4:00:01β€―PM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for RLYB...
Open
$16.02
High
$16.23
Low
$15.79
Mkt. cap
84.61M
Avg. vol.
83.62K
Volume
28.97K
52-wk high
$17.57
52-wk low
$2.40
EPS
-$1.37
Beta
-0.88
Shares outstanding
5.30M
No. of employees
9
Open
$16.02
High
$16.23
Low
$15.79
Mkt. cap
84.61M
Avg. vol.
83.62K
Volume
28.97K
52-wk high
$17.57
52-wk low
$2.40
EPS
-$1.37
Beta
-0.88
Shares outstanding
5.30M
No. of employees
9
News stories
From sources across the web
About Rallybio Corp
CEO-
Employees9
Founded2018
HeadquartersNew Haven, Connecticut, United States
SectorBiotechnology
Last report
May 7, 2026
Fiscal period
Q1 2026
EPS / Est. (USD)
-$1.46 / -$1.20
-21.67%miss
Revenue / Est. (USD)
212.00K / 0.00
+∞%beat
Fiscal Q1 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Revenue
212.00K
212.00K
222.00K
212.00K
Cost of goods sold
6.07M
4.14M
3.66M
-
Cost of revenue
6.07M
4.14M
3.66M
-
Research and development expenses
-
-
-
2.87M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
4.20M
2.99M
2.98M
6.07M
Operating expense
4.20M
2.99M
2.98M
8.94M
Total operating expenses
10.27M
7.14M
6.63M
8.94M
Operating income
-10.06M
-6.92M
-6.41M
-8.73M
Other non operating income
118.00K
-
-
254.00K
EBT including unusual items
-9.70M
16.02M
-5.85M
-8.28M
EBT excluding unusual items
-9.70M
-6.46M
-5.85M
-8.28M
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-9.70M
16.02M
-5.85M
-8.28M
Net profit margin
-4,576.89%
7,554.72%
-2,636.04%
-3,904.72%
Earnings per share
-1.76
2.88
-1.52
-1.46
Interest and investment income
523.00K
462.00K
560.00K
201.00K
Interest expense
-
-
-
-
Net interest expenses
523.00K
462.00K
560.00K
201.00K
Depreciation and amortization charges
-
-
-
-
EBITDA
-10.03M
-6.89M
-6.41M
-8.73M
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
AI content may include mistakes. Learn more